Financhill
Buy
55

GILD Quote, Financials, Valuation and Earnings

Last price:
$92.57
Seasonality move :
8.55%
Day range:
$90.71 - $93.29
52-week range:
$62.07 - $98.90
Dividend yield:
3.33%
P/E ratio:
1,028.56x
P/S ratio:
4.09x
P/B ratio:
6.24x
Volume:
22.4M
Avg. volume:
7.7M
1-year change:
17.79%
Market cap:
$115.4B
Revenue:
$27.1B
EPS (TTM):
$0.09
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $22.4B $24.7B $27.3B $27.3B $27.1B
Revenue Growth (YoY) 1.46% 9.98% 10.6% -0.09% -0.61%
 
Cost of Revenues $4.7B $4.6B $6.6B $5.7B $6.5B
Gross Profit $17.8B $20.1B $20.7B $21.6B $20.6B
Gross Profit Margin 79.18% 81.48% 75.83% 79.26% 76.04%
 
R&D Expenses $4.1B $5B $4.6B $5B $5.7B
Selling, General & Admin $4.4B $5.2B $5.2B $5.7B $6.1B
Other Inc / (Exp) -$3.2B -$7.3B -$1.6B -$4.2B -$1B
Operating Expenses $8.4B $10.2B $9.8B $10.7B $11.8B
Operating Income $9.3B $9.9B $10.9B $11B $8.8B
 
Net Interest Expenses $995M $984M $1B $935M $944M
EBT. Incl. Unusual Items $5.2B $1.7B $8.3B $5.8B $6.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$204M $1.6B $2.1B $1.2B $1.2B
Net Income to Company $5.4B $89M $6.2B $4.6B $5.6B
 
Minority Interest in Earnings $22M $34M $24M $26M $52M
Net Income to Common Excl Extra Items $5.4B $123M $6.2B $4.6B $5.7B
 
Basic EPS (Cont. Ops) $4.24 $0.10 $4.96 $3.66 $4.54
Diluted EPS (Cont. Ops) $4.22 $0.10 $4.93 $3.64 $4.50
Weighted Average Basic Share $1.3B $1.3B $1.3B $1.3B $1.2B
Weighted Average Diluted Share $1.3B $1.3B $1.3B $1.3B $1.3B
 
EBITDA $7.6B $4.1B $11.3B $8.9B $10.5B
EBIT $6.2B $2.7B $9.3B $6.7B $7.8B
 
Revenue (Reported) $22.4B $24.7B $27.3B $27.3B $27.1B
Operating Income (Reported) $9.3B $9.9B $10.9B $11B $8.8B
Operating Income (Adjusted) $6.2B $2.7B $9.3B $6.7B $7.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $6.6B $7.4B $7B $7.1B $7.5B
Revenue Growth (YoY) 17.36% 12.83% -5.11% 0.11% 7.02%
 
Cost of Revenues $1.1B $1.2B $1.4B $1.6B $1.6B
Gross Profit $5.4B $6.2B $5.6B $5.5B $6B
Gross Profit Margin 82.65% 83.52% 80.19% 77.8% 79.14%
 
R&D Expenses $1.2B $1.1B $1.1B $1.5B $1.4B
Selling, General & Admin $1.1B $1.2B $1.2B $1.3B $1.4B
Other Inc / (Exp) -$2.1B -$219M -$624M -$269M -$2B
Operating Expenses $2.3B $2.3B $2.4B $2.8B $2.8B
Operating Income $3.2B $3.9B $3.3B $2.7B $3.1B
 
Net Interest Expenses $236M $250M $229M $126M $186M
EBT. Incl. Unusual Items $825M $3.4B $2.4B $2.3B $956M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $472M $852M $646M $146M -$297M
Net Income to Company $353M $2.6B $1.8B $2.2B $1.3B
 
Minority Interest in Earnings $7M $6M $3M $8M --
Net Income to Common Excl Extra Items $360M $2.6B $1.8B $2.2B $1.3B
 
Basic EPS (Cont. Ops) $0.29 $2.06 $1.43 $1.75 $1.00
Diluted EPS (Cont. Ops) $0.29 $2.05 $1.42 $1.73 $1.00
Weighted Average Basic Share $1.3B $1.3B $1.3B $1.2B $1.2B
Weighted Average Diluted Share $1.3B $1.3B $1.3B $1.3B $1.3B
 
EBITDA $1.4B $4.2B $3.2B $3.2B $1.9B
EBIT $1.1B $3.7B $2.7B $2.6B $1.2B
 
Revenue (Reported) $6.6B $7.4B $7B $7.1B $7.5B
Operating Income (Reported) $3.2B $3.9B $3.3B $2.7B $3.1B
Operating Income (Adjusted) $1.1B $3.7B $2.7B $2.6B $1.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $23.1B $27.5B $27.1B $27.4B $28.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $4.9B $5.4B $6.9B $5.8B $6.8B
Gross Profit $18.3B $22.1B $20.2B $21.6B $21.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $4.6B $4.8B $7.5B $3.2B $8.1B
Selling, General & Admin $4.6B $5.3B $5.3B $6.5B $5.8B
Other Inc / (Exp) -$6.4B -$1.6B -$2B -$3.9B -$6.3B
Operating Expenses $9.2B $10.2B $12.8B $9.7B $13.9B
Operating Income $9.1B $12B $7.5B $11.9B $7.6B
 
Net Interest Expenses $960M $1B $947M $812M $1.2B
EBT. Incl. Unusual Items $1.8B $9.3B $4.5B $7.2B $176M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $522M $2B $1.2B $1.4B $63M
Net Income to Company $1.2B $7.4B $3.3B $5.8B $114M
 
Minority Interest in Earnings $34M $25M $25M $47M $12M
Net Income to Common Excl Extra Items $1.3B $7.4B $3.3B $5.9B $126M
 
Basic EPS (Cont. Ops) $0.99 $5.89 $2.66 $4.71 $0.10
Diluted EPS (Cont. Ops) $0.97 $5.86 $2.65 $4.66 $0.09
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $4.1B $12.3B $7.6B $10.7B $3.9B
EBIT $2.7B $10.4B $5.5B $8.2B $1.2B
 
Revenue (Reported) $23.1B $27.5B $27.1B $27.4B $28.3B
Operating Income (Reported) $9.1B $12B $7.5B $11.9B $7.6B
Operating Income (Adjusted) $2.7B $10.4B $5.5B $8.2B $1.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $17.3B $20.1B $19.9B $20B $21.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $3.2B $4B $4.3B $4.4B $4.7B
Gross Profit $14.1B $16.1B $15.6B $15.6B $16.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $3.5B $3.2B $6.1B $4.3B $6.7B
Selling, General & Admin $3.4B $3.6B $3.7B $4.5B $4.2B
Other Inc / (Exp) -$6.6B -$961M -$1.4B -$1B -$6.4B
Operating Expenses $6.9B $6.8B $9.8B $8.8B $10.9B
Operating Income $7.2B $9.2B $5.8B $6.8B $5.6B
 
Net Interest Expenses $717M $763M $709M $586M $677M
EBT. Incl. Unusual Items -$145M $7.5B $3.8B $5.2B -$1.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.3B $1.7B $850M $1B -$174M
Net Income to Company -$1.5B $5.8B $2.9B $4.2B -$1.3B
 
Minority Interest in Earnings $27M $18M $19M $40M --
Net Income to Common Excl Extra Items -$1.4B $5.8B $3B $4.2B -$1.3B
 
Basic EPS (Cont. Ops) -$1.14 $4.65 $2.36 $3.40 -$1.05
Diluted EPS (Cont. Ops) -$1.15 $4.63 $2.35 $3.36 -$1.05
Weighted Average Basic Share $3.8B $3.8B $3.8B $3.7B $3.7B
Weighted Average Diluted Share $3.8B $3.8B $3.8B $3.8B $3.8B
 
EBITDA $1.6B $9.8B $6.1B $7.9B $1.3B
EBIT $572M $8.3B $4.5B $5.9B -$748M
 
Revenue (Reported) $17.3B $20.1B $19.9B $20B $21.2B
Operating Income (Reported) $7.2B $9.2B $5.8B $6.8B $5.6B
Operating Income (Adjusted) $572M $8.3B $4.5B $5.9B -$748M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $11.6B $6B $5.3B $5.4B $6.1B
Short Term Investments $12.7B $1.4B $1.2B $973M $1.2B
Accounts Receivable, Net $3.6B $4.9B $4.5B $4.8B $4.7B
Inventory $922M $1.7B $1.6B $1.5B $1.8B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.4B $2B $2.1B $1.8B $2.4B
Total Current Assets $30.3B $16B $14.8B $14.4B $16.1B
 
Property Plant And Equipment $4.5B $5B $5.1B $5.5B $5.3B
Long-Term Investments $1.5B $502M $1.3B $1.2B $1.2B
Goodwill $4.1B $8.1B $8.3B $8.3B $8.3B
Other Intangibles $13.8B $33.1B $33.5B $28.9B $26.5B
Other Long-Term Assets $7.4B $5.7B $5B $4.8B $4.8B
Total Assets $61.6B $68.4B $68B $63.2B $62.1B
 
Accounts Payable $713M $844M $705M $905M $550M
Accrued Expenses $5.5B $5.7B $7.4B $3.5B $3.8B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- $2.2B $2.3B
Total Current Liabilities $9.8B $11.4B $11.6B $11.2B $11.3B
 
Long-Term Debt $22.1B $28.6B $25.2B $23B $23.2B
Capital Leases -- -- -- -- --
Total Liabilities $39B $50.2B $46.9B $42B $39.4B
 
Common Stock $1M $1M $1M $1M $1M
Other Common Equity Adj $85M -$60M $83M $2M $28M
Common Equity $22.5B $18.2B $21.1B $21.2B $22.8B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $125M $19M -$5M -$31M -$84M
Total Equity $22.7B $18.2B $21.1B $21.2B $22.7B
 
Total Liabilities and Equity $61.6B $68.4B $68B $63.2B $62.1B
Cash and Short Terms $24.4B $7.4B $6.5B $6.4B $7.3B
Total Debt $24.6B $31.4B $26.7B $25.2B $25B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $12.9B $4.4B $4.7B $5.7B $5B
Short Term Investments $11.1B $1.4B $961M $1.2B --
Accounts Receivable, Net $3.9B $4.6B $4.4B $4.8B $4.6B
Inventory $1B $1.7B $1.5B $1.7B $1.9B
Prepaid Expenses -- -- -- -- --
Other Current Assets $2B $2B $2.1B $2.7B $3.3B
Total Current Assets $30.9B $14B $13.6B $16B $14.8B
 
Property Plant And Equipment $4.8B $5B $5.3B $5.6B $5.4B
Long-Term Investments $2.1B $1.1B $1.3B $1.2B --
Goodwill $4.1B $8.3B $8.3B $8.3B $8.3B
Other Intangibles $12.9B $33.9B $29.4B $27.2B $20.5B
Other Long-Term Assets $6B $4.7B $4.6B $4.2B $5.5B
Total Assets $60.9B $67.1B $62.6B $62.4B $54.5B
 
Accounts Payable $527M $585M $614M $586M $903M
Accrued Expenses $5.9B $5.5B $5.5B $3.7B $4.1B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- $2.4B $2B
Total Current Liabilities $9.5B $10.2B $10.4B $11.9B $11.7B
 
Long-Term Debt $27.8B $25.2B $23B $23.2B $21.4B
Capital Leases -- -- -- -- --
Total Liabilities $43.4B $45.6B $41.5B $40.1B $36.1B
 
Common Stock $1M $1M $1M $1M $1M
Other Common Equity Adj $23M $74M $98M $31M $73M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $26M $1M -$24M -$72M -$84M
Total Equity $17.5B $21.5B $21.1B $22.2B $18.4B
 
Total Liabilities and Equity $60.9B $67.1B $62.6B $62.4B $54.5B
Cash and Short Terms $24B $5.7B $5.7B $6.9B $5B
Total Debt $29.3B $27.7B $25.2B $25B $23.2B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $5.4B $89M $6.2B $4.6B $5.6B
Depreciation & Amoritzation $1.4B $1.5B $2.1B $2.1B $2.7B
Stock-Based Compensation $636M $643M $635M $637M $766M
Change in Accounts Receivable -$218M -$1.2B $313M -$406M $157M
Change in Inventories -$95M -$195M $11M -$310M -$842M
Cash From Operations $9.1B $8.2B $11.4B $9.1B $8B
 
Capital Expenditures $825M $650M $579M $728M $585M
Cash Acquisitions -$4.3B -$25.7B -$1.6B -$1.8B -$1.2B
Cash From Investing -$7.8B -$14.6B -$3.1B -$2.5B -$2.3B
 
Dividends Paid (Ex Special Dividend) -$3.2B -$3.4B -$3.6B -$3.7B -$3.8B
Special Dividend Paid
Long-Term Debt Issued -- $8.2B -- -- $2B
Long-Term Debt Repaid -$2.8B -$2.5B -$4.8B -$1.5B -$2.3B
Repurchase of Common Stock -$1.7B -$1.6B -$546M -$1.4B -$1B
Other Financing Activities -$122M -$138M -$145M -$173M -$278M
Cash From Financing -$7.6B $770M -$8.9B -$6.5B -$5.1B
 
Beginning Cash (CF) $17.9B $11.6B $6B $5.3B $5.4B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$6.3B -$5.7B -$624M $137M $616M
Ending Cash (CF) $11.6B $6B $5.3B $5.4B $6.1B
 
Levered Free Cash Flow $8.3B $7.5B $10.8B $8.3B $7.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $353M $2.6B $1.8B $2.2B $1.3B
Depreciation & Amoritzation $355M $523M $525M $684M $690M
Stock-Based Compensation $173M $171M $168M $202M $216M
Change in Accounts Receivable -$702M -$422M -$372M -$612M $162M
Change in Inventories -$26M $70M -$95M -$82M -$85M
Cash From Operations $2.3B $3.3B $2.9B $1.8B $4.3B
 
Capital Expenditures $155M $139M $157M $122M $141M
Cash Acquisitions -$1B -$83M -$448M -$79M -$570M
Cash From Investing -$271M -$234M -$713M -$229M -$710M
 
Dividends Paid (Ex Special Dividend) -$861M -$900M -$929M -$953M -$983M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $7.2B -- -- $2B --
Long-Term Debt Repaid -$2B -$2.5B -$1B -$2.3B -$112M
Repurchase of Common Stock -$201M -$145M -$180M -$300M -$300M
Other Financing Activities -$39M -$39M -$45M -$78M -$82M
Cash From Financing $4.1B -$3.5B -$2.1B -$1.5B -$1.4B
 
Beginning Cash (CF) $6.7B $4.9B $4.7B $5.7B $2.8B
Foreign Exchange Rate Adjustment $37M -$23M -$72M -$6M $44M
Additions / Reductions $6.1B -$508M $32M $7M $2.2B
Ending Cash (CF) $12.9B $4.4B $4.7B $5.7B $5B
 
Levered Free Cash Flow $2.1B $3.1B $2.7B $1.6B $4.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $1.2B $7.4B $3.3B $5.8B $114M
Depreciation & Amoritzation $1.4B $1.9B $2.1B $2.5B $2.8B
Stock-Based Compensation $639M $637M $622M $739M $814M
Change in Accounts Receivable -$585M -$565M -$84M -$344M $287M
Change in Inventories -$108M -$171M $1M -$811M -$507M
Cash From Operations $8.8B $10.1B $9.7B $8.4B $10B
 
Capital Expenditures $672M $604M $703M $551M $591M
Cash Acquisitions -$5.8B -$21.5B -$1.6B -$1.1B -$5B
Cash From Investing -$5.2B -$11.8B -$2.4B -$1.9B -$4B
 
Dividends Paid (Ex Special Dividend) -$3.4B -$3.6B -$3.7B -$3.8B -$3.9B
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$2.5B -$3.8B -$2.5B -- --
Repurchase of Common Stock -$1.7B -$497M -$653M -$1.6B -$950M
Other Financing Activities -$141M -$148M -$161M -$268M -$267M
Cash From Financing -$257M -$6.8B -$6.9B -$5.6B -$6.8B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $3.4B -$8.5B $484M $911M -$720M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $8.2B $9.5B $9B $7.9B $9.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$1.5B $5.8B $2.9B $4.2B -$1.3B
Depreciation & Amoritzation $1.1B $1.5B $1.6B $2B $2.1B
Stock-Based Compensation $482M $476M $463M $565M $613M
Change in Accounts Receivable -$334M $272M -$125M -$63M $67M
Change in Inventories -$48M -$24M -$34M -$535M -$200M
Cash From Operations $6.3B $8.2B $6.5B $5.8B $7.9B
 
Capital Expenditures $469M $423M $547M $370M $376M
Cash Acquisitions -$5.8B -$1.5B -$1.6B -$873M -$4.8B
Cash From Investing -$5.6B -$2.9B -$2.1B -$1.5B -$3.2B
 
Dividends Paid (Ex Special Dividend) -$2.6B -$2.7B -$2.8B -$2.9B -$2.9B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $7.2B -- -- $2B --
Long-Term Debt Repaid -$2.5B -$3.8B -$1.5B -$2.3B -$2B
Repurchase of Common Stock -$1.6B -$497M -$604M -$850M -$800M
Other Financing Activities -$124M -$134M -$150M -$245M -$234M
Cash From Financing $639M -$6.9B -$4.9B -$4B -$5.7B
 
Beginning Cash (CF) $28.4B $15B $14.4B $16.1B $13.6B
Foreign Exchange Rate Adjustment $2M -$26M -$138M $20M $15M
Additions / Reductions $1.3B -$1.6B -$501M $273M -$1.1B
Ending Cash (CF) $29.7B $13.3B $13.7B $16.3B $12.5B
 
Levered Free Cash Flow $5.8B $7.8B $6B $5.5B $7.5B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock